Healios K.K. (OTCMKTS:HLOSF – Get Free Report) dropped 28.9% during mid-day trading on Thursday . The company traded as low as $0.96 and last traded at $0.96. Approximately 100 shares changed hands during trading, a decline of 96% from the average daily volume of 2,332 shares. The stock had previously closed at $1.35.
Healios K.K. Stock Performance
The business has a fifty day simple moving average of $1.35 and a two-hundred day simple moving average of $1.39.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Further Reading
- Five stocks we like better than Healios K.K.
- Trading Halts Explained
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Dividend Capture Strategy: What You Need to Know
- Nebius Group: The Rising Star in AI Infrastructure
- Overbought Stocks Explained: Should You Trade Them?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
